Understanding mTOR signalling and angiogenesis pathways, which are abnormally activated in neuroendocrine tumours, has made it possible to create targeted therapies

Authors
Tamara Matysiak-Budnik, CHU de Nantes, Nantes, France
Authors
Tamara Matysiak-Budnik, CHU de Nantes, Nantes, France
Category
Oncology
Publication type
Proceedings
Year
2019
Download the publication